Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications As mRNA developments continue to dominate industry news, […]

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various […]

There has been many exciting investments and advancements in the field, such as Atavistik Bio raising an additional $40 million to advance their small molecule therapeutics and Servier and Base4 […]

Optimize Safety & De-Risk Efficacy of Viral Vector-Based Gene Therapies The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies […]

With Eli Lilly's acquisition of Mablink and Novartis' investment in Tagworks, both centering on their innovative linker and conjugation technologies - optimizing linker chemistry and diversifying conjugation technologies to increase stability and selectivity are becoming increasingly more […]

Delivering on the Promise of Precision Medicine with Digital Measures in Neurology Harnessing More Quantitative, Objective & Less Invasive Measures to Reduce Costs & Improve Neurology Patient Experience 2023 welcomed SV95C as […]

Exclusively dedicated to uniting AD, QC, and CMC leaders the 3rd Oligonucleotide CMC & Analytical Development Summit is the only industry-led meeting solving your impurity, regulatory, and cost-efficiency challenges in […]

Bringing together technical experts, the 3rd Cell Therapy Analytical Development Summit Europe, is the definitive summit dedicated to defining and refining analytics to ensure the swift progression of highly efficacious products through […]

The Wearable Injectors and Connected Devices event is the only conference that discusses both wearable injectors and connected devices in one event. Over two days, we bring together executives within […]

Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind […]

SAE Media Group are proud to announce the inaugural Pre-Filled Syringes Connect event taking place on the 11th and 12th of September in Boston. As a new addition to SAE's […]

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 […]

Develop, characterize, and validate robust analytical tools that demonstrate safety, efficacy, and regulatory compliance of genome editing therapies As CRISPR-based therapies become ever-complex, drug developers urgently need to innovate the […]

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond The mRNA manufacturing industry […]

With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield, optimize purification, and streamline production to meet regulatory standards […]

The race to target the remaining RAS mutants continues, with over 24 clinical and 70 pre-clinical stage programs striving for first- and best-in-class. Now more than ever, we are witnessing […]

Join us for an exploration of accelerating drug development, streamlining clinical trials and enhancing supply chain efficiency to elevate patient care across the entire value stream at the AI for […]

With Rezdiffra’s approval, GLPs moving into the space, and the wave of promising therapeutics in phrase I-III trials, MASH therapeutics have seen an unprecedented boom in recent months. Don't miss […]

Learning From the Past & Spearheading Macrophage Clinical Acceleration The 6th Macrophage-Directed Therapies Summit is uniting 60+ biopharma and academia leaders across R&D, Discovery, Biology, Translational, and Clinical Development fields […]

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of […]

SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health […]

Are you listening to your patient community? It’s not enough. Standing in the shadows and harvesting anecdotal insights won’t build connections, create first-hand knowledge or illuminate your impact to internal […]

Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies […]

The 5th Commercializing Flow Chemistry Summit marks a pivotal year, introducing a significant shift in content to address the evolving needs of the pharmaceutical manufacturing industry. This summit zeroes in […]

𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? The knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success […]

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It […]

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively […]

Spurred by George Schett and Andreas Mackensen’s remarkable CAR-T results in SLE, the immunotherapy revolution for autoimmune diseases is the next “million-dollar question”. The Autoimmunity Pharma & Biotech Partnering Summit […]

Discover the future of drug discovery at the inaugural Hit ID Summit! As chemical libraries and hit screening methods—including DNA-encoded libraries, high-throughput screening, fragment-based screening, and AI—continue to evolve, now […]

The advanced therapy immuno-inflammatory dermatology market is undergoing unprecedented expansion, as Johnson & Johnson make a $3.35B play for bispecific candidates, Alumis secured $259M series C and Galderma, Incyte, and […]